Close Menu

This article has been updated with additional information from Foundation Medicine.

NEW YORK (GenomeWeb) – The US Food and Drug Administration has approved Foundation Medicine's NGS-based genomic profiling test, FoundationOne CDx (F1CDx), the agency said today. Concurrently, the Centers for Medicare and Medicaid Services (CMS) issued a preliminary national coverage determination for the test and others like it.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jun
18
Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect. 

Jun
19

This webinar will discuss cell-free DNA prenatal screening in the era of genome-wide sequencing and factors influencing the clinical utility of expanded noninvasive prenatal testing (NIPT) menus.

Jul
23
Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients.